CLINICAL_TRIALS ClinicalTrials.gov record update

Pilot Study of Oral Rifaximin in Patients With Monoclonal Gammopathy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03820817
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:35.811197+00:00
Published At: 2025-04-20T00:00:00+00:00
Record Updated At: 2025-04-20
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["IgA Monoclonal Gammopathy", "IgG Monoclonal Gammopathy", "IgM Monoclonal Gammopathy", "Light Chain Deposition Disease", "Monoclonal Gammopathy", "Smoldering Waldenstrom Macroglobulinemia", "Waldenstrom Macroglobulinemia", "Gammopathy, Monoclonal", "Gammopathy Igg"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-04-20"
protocolSection.identificationModule.nctId: "NCT03820817"
protocolSection.identificationModule.officialTitle: "Pilot Study of Oral Rifaximin in Patients With Monoclonal Gammopathy"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.